EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast

Chiara M Ciniselli, Paolo Verderio, Paolo Baili, Milena Sant, Sara Pizzamiglio, Valeria Duroni, Filippo G de Braud, Secondo Folli, Gianfranco Scaperrotta, Maria C De Santis, Giovanni Apolone, Cinzia De Marco und 4 weitere

Clinical Breast Cancer · 2025

DOI: 10.1016/j.clbc.2024.08.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Breast Cancer, 2025. Verfasst von Chiara M Ciniselli und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Data Science, Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesBreast NeoplasmsCarcinoma, Intraductal, NoninfiltratingNeoplasm Recurrence, LocalBiomarkers, TumorHumansFemaleMiddle AgedAdultAgedAged, 80 and overFollow-Up StudiesPrognosisMastectomy, SegmentalProspective StudiesReceptors, Estrogen

Stichwörter der Autor:innen

DCISHuman epidermal growth factor receptor 2Immunohistochemistry (IHC)Ipsilateral loco-regional recurrence (LRR)Paired primary tumor and LRR

Substanzen

Erb-b2 Receptor Tyrosine KinasesBiomarkers, TumorReceptors, EstrogenERBB2 protein, human

Autor:innen und Institutionen

  • Department of Epidemiology and Data Science, Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Department of Epidemiology and Data Science, Bioinformatics and Biostatistics Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: paolo.verderio@istitutotumori.mi.it.
  • Department of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Analytical Epidemiology and Health Impact Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Department of Medical Oncology and Hematology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; University of Milan, Milano, Italy.
  • Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.

Zitieren

APA

Ciniselli, C. M., Verderio, P., Baili, P., Sant, M., Pizzamiglio, S., Duroni, V., de Braud, F. G., Folli, S., Scaperrotta, G., De Santis, M. C., Apolone, G., De Marco, C., Vingiani, A., Cappelletti, V., Pruneri, G., & Di Cosimo, S. (2025). Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast. Clinical Breast Cancer. https://doi.org/10.1016/j.clbc.2024.08.002

Vancouver

Ciniselli CM, Verderio P, Baili P, Sant M, Pizzamiglio S, Duroni V, et al. Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast. Clinical Breast Cancer. 2025. doi:10.1016/j.clbc.2024.08.002

BibTeX
@article{Ciniselli2025,
  author = {Ciniselli, Chiara M and Verderio, Paolo and Baili, Paolo and Sant, Milena and Pizzamiglio, Sara and Duroni, Valeria and de Braud, Filippo G and Folli, Secondo and Scaperrotta, Gianfranco and De Santis, Maria C and Apolone, Giovanni and De Marco, Cinzia and Vingiani, Andrea and Cappelletti, Vera and Pruneri, Giancarlo and Di Cosimo, Serena},
  title = {Clinical and Biological Significance of HER2-Low in Ductal Carcinoma In Situ of the Breast},
  journal = {Clinical Breast Cancer},
  year = {2025},
  doi = {10.1016/j.clbc.2024.08.002}
}
Kostenlos starten →